I concur with your rationale Fishy, although certainly not my preference for a T/O. With the big pharma's pinching a few more pennies and looking further abroad for their R&D from small fry like our little engine that could, the obvious being trial results driven, you'd be made not to put yourself in the shoes of a player in acquisitions. I would truly hate for it to pan out that way. Only M/O
Domino Effect, page-16
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.3¢ |
Change
0.018(6.14%) |
Mkt cap ! $486.6M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 30.8¢ | 29.0¢ | $833.5K | 2.792M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 254152 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 174886 | 16 |
View Market Depth
| Last trade - 14.54pm 22/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |
